(Q77751625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

main subject

cost–benefit analysis

1 reference

2

G Dranitsaris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

A Ortega

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A L Puodziunas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

2588-2596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

Red blood cell transfusions for anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

Transfusion requirements, risks, and costs for patients with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

Assessing the economic value of a new antidepressant. A willingness-to-pay approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981215%2983%3A12%3C2588%3A%3AAID-CNCR26%3E3.0.CO%3B2-M

10.1002/(SICI)1097-0142(19981215)83:12<2588::AID-CNCR26>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874467%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference